New Delhi: To prevent three common pathogens of traveller's diarrhea, a vaccine has been designed which is first of its kind. The study founded that the approach to develop a new vaccine could save lives in developing countries. In these countries these pathogens kill over 100,000 children under the age of five every year.
The study found out that the conjugate vaccine binds together proteins from pathogenic E coli with sugars from Shigella and Campylobacter jejuni.
These are the three bugs which primarily contribute the global spread of the disease.